Author

C. Sugai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

L. C. Ndhlovu· 1 shared M. J. Corley· 1 shared M. Schotsaert· 1 shared R. E. Schwartz· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

L. C. Ndhlovu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes.

M. J. Corley, C. Sugai, M. Schotsaert, R. E. Schwartz, L. C. Ndhlovu

This study examines HCQ's transcriptomic effects in vitro and finds limited overlap with SARS-CoV-2 host response genes, suggesting limited immunomodulatory evidence for HCQ in COVID-19.

bioRxiv · Apr 13, 2020 · PreprintImmunology